Literature DB >> 22332836

Ancestral mutations may cause a significant proportion of GCK-MODY.

Petra Dusatkova1, Stepanka Pruhova, Maciej Borowiec, Klara Vesela, Karolina Antosik, Jan Lebl, Wojciech Mlynarski, Ondrej Cinek.   

Abstract

BACKGROUND: Although the literature indicates that ancestral mutations in the glucokinase (GCK) gene are rare, we have detected a high frequency of four prevalent mutations that together are responsible for over one third of the GCK mutations in our Czech National Register of monogenic diabetes. Therefore, we studied their potential ancestral origin in our and neighbouring Polish populations.
METHODS: We analysed the lineage of four mutations in the GCK gene - p.Glu40Lys (21 apparently unrelated families), p.Leu315His (15 families), p.Gly318Arg (26 families), and p.Val33Ala (10 families) - using genotypes of 16 single nucleotide polymorphisms that span a 14 Mb region around the gene. Haplotypes were reconstructed using Phase and Haploview programmes, and their age was estimated using dmle+.
RESULTS: We found strong evidence that supports ancestral origin of three of the four mutations: the p.Glu40Lys mutation was associated with an 11-marker long conserved haplotype, the p.Leu315His mutation was associated with a 7-marker haplotype, and the p.Gly318Arg mutation was associated with an 8-marker haplotype. None of these haplotypes were detected in the general population with a frequency >0.5%. The ages of the mutations were roughly estimated to be between 82 and 110 generations old (95% credible sets 65-151). The fourth prevalent mutation, p.Val33Ala, lacked statistically significant evidence for the founder effect, although there were some indications for its common origin.
CONCLUSIONS: The large proportion of families carrying three ancestral mutations in GCK indicates that the previously assumed rarity of the founder effect with regard to GCK-maturity onset diabetes of the young (MODY) should be reconsidered.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22332836     DOI: 10.1111/j.1399-5448.2011.00845.x

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  3 in total

1.  Clinical utility gene card for: Maturity-onset diabetes of the young.

Authors:  Kevin Colclough; Cécile Saint-Martin; José Timsit; Sian Ellard; Christine Bellanné-Chantelot
Journal:  Eur J Hum Genet       Date:  2014-02-12       Impact factor: 4.246

2.  Genesis of two most prevalent PROP1 gene variants causing combined pituitary hormone deficiency in 21 populations.

Authors:  Petra Dusatkova; Roland Pfäffle; Milton R Brown; Natallia Akulevich; Ivo J P Arnhold; Maria A Kalina; Karolina Kot; Ciril Krzisnik; Manuel C Lemos; Jana Malikova; Ruta Navardauskaite; Barbora Obermannova; Zuzana Pribilincova; Agnes Sallai; Gordana Stipancic; Rasa Verkauskiene; Ondrej Cinek; Werner F Blum; John S Parks; Frederic Austerlitz; Jan Lebl
Journal:  Eur J Hum Genet       Date:  2015-06-10       Impact factor: 4.246

3.  The Common p.R114W HNF4A Mutation Causes a Distinct Clinical Subtype of Monogenic Diabetes.

Authors:  Thomas W Laver; Kevin Colclough; Maggie Shepherd; Kashyap Patel; Jayne A L Houghton; Petra Dusatkova; Stepanka Pruhova; Andrew D Morris; Colin N Palmer; Mark I McCarthy; Sian Ellard; Andrew T Hattersley; Michael N Weedon
Journal:  Diabetes       Date:  2016-08-02       Impact factor: 9.461

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.